Impact of molecular staging methods in primary melanoma: Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of Peripheral blood does predict survival

Journal of Clinical Oncology

Volumn 26, Issue 35, 2008, Pages 5742-5747

  Voit, Christiane A ^a   Schäfer Hesterberg, Gregor ^a   Kron, Martina ^a   Van Akkooi, Alexander C J ^a   Rademaker, Juergen ^a   Lukowsky, Ansgar ^a   Schoengen, Alfred ^a   Schwürzer Voit, Markus ^a   Sterry, Wolfram ^a   Krause, Markus ^a   Röwert Huber, Joachim ^a   Eggermont, Alexander M M ^a  

^a HUMBOLDT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CANCER SURVIVAL; CYTOLOGY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 57449102060     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.7653     Document Type: Article

References (33)

1. Morton DL, Hoon DS, Cochran AJ, et al: Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238:538-549, 2003
2. Rossi CR, Seno A, Vecchiato A, et al: The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur J Cancer 33:200-203, 1997
3. Voit C, Mayer T, Proebstle TM, et al: Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases. Cancer 90:186-193, 2000
4. Voit C, Mayer T, Kron M, et al: Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91:2409-2416, 2001
5. Voit C, Schoengen A, Schwurzer-Voit M, et al: The role of ultrasound in detection and management of regional disease in melanoma patients. Semin Oncol 29:353-360, 2002
6. Bonnema J, van Geel AN, van Ooijen B, et al: Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: New diagnostic method. World J Surg 21:270-274, 1997
7. de Kanter AY, Menke-Pluijmers MB, Henzen-Logmans SC, et al: Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement. Eur J Surg Oncol 32:498-501, 2006
8. Voit C, Kron M, Schafer G, et al: Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 13:1682-1689, 2006
9. Morton DL, Thompson JF, Cochran AJ, et al: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307-1317, 2006
10. Gershenwald JE, Colome MI, Lee JE, et al: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253-2260, 1998
11. Dewar DJ, Newell B, Green MA, et al: The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22:3345-3349, 2004
12. van Akkooi A, de Wilt J, Verhoef C, et al: Clinical relevance of melanoma micrometastases (< 0.1 mm) in sentinel nodes: Are these nodes to be considered negative? Ann Oncol 17:1578-1585, 2006
13. van Akkooi AC, de Wilt JH, Verhoef C, et al: High positive sentinel node identification rate by EORTC melanoma group protocol: Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 42:372-380, 2006
14. Voit C, Schoengen A, Schwurzer M, et al: Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates. Br J Cancer 80:1672-1677, 1999
15. Voit C, Schoengen A, Weber L, et al: Identification of melanoma metastases by tyrosinasereverse transcription-polymerase chain reaction of fine needle aspirates. J Am Acad Dermatol 39:1030-1032, 1998
16. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
17. Proebstle TM, Jiang W, Hogel J, et al: Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors. Br J Cancer 82:118-123, 2000
18. Max N, Wolf K, Spike B, et al: Nested quantitative real time PCR for detection of occult tumor cells. Recent Results Cancer Res 158:25-31, 2001
19. Max N, Willhauck M, Wolf K, et al: Reliability of PCR-based detection of occult tumour cells: Lessons from real-time RT-PCR. Melanoma Res 11:371-378, 2001
20. Keilholz U, Willhauck M, Rimoldi D, et al: Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: A quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur J Cancer 34:750-753, 1998
21. Voit C, Kron M, Rademaker J, et al: Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol 23:1218-1227, 2005
22. Max N, Wolf K, Thiel E, et al: Quantitative nested real-time RT-PCR specific for tyrosinase transcripts to quantitate minimal residual disease. Clin Chim Acta 317:39-46, 2002
23. Lawless JL: Statistical models and methods for lifetime data. New York, NY, John Wiley & Sons, 1982
24. de Kanter AY, van Eijck CH, van Geel AN, et al: Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86:1459-1462, 1999
25. Eggermont AM: Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodes. Ann Surg Oncol 12:3-5, 2005
26. Scoggins CR, Ross MI, Reintgen DS, et al: Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 24:2849-2857, 2006
27. Mocellin S, Hoon DS, Pilati P, et al: Sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis of prognosis. J Clin Oncol 25:1588-1595, 2007
28. Cook MG, Green MA, Anderson B, et al: The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 200:314-319, 2003
29. Ghossein RA, Coit D, Brennan M, et al: Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4:419-428, 1998
30. Hoon DS, Wang Y, Dale PS, et al: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995
31. Kuo CT, Hoon DS, Takeuchi H, et al: Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol 21:3566-3572, 2003
32. Osella-Abate S, Savoia P, Quaglino P, et al: Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: A clinical follow-up study of 110 patients. Br J Cancer 89:1457-1462, 2003
33. Quaglino P, Osella-Abate S, Savoia P, et al: What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients? J Clin Oncol 25:1140-1141, 2007